Vaccine News and Research

Latest Vaccine News and Research

New combination offers complete protection against malaria

This ingredient is an essential component of the malaria parasite, a protein known as RPL6, which makes the parasite "visible" to a type of immune cells, the T cells, in the liver.

14 May 2020

Experts highlight triumph over polio and hope to do the same for COVID-19

For much of the 20th century, summer was considered "polio season," and people were accustomed to seeing swimming pools and movie theaters closed to stave off the latest epidemic. Shaking hands was off limits, and even touching money was perilous.

14 May 2020

Relaxation of social and physical distancing measures may result in profound mortality

Even as the world struggles to live and make a living, faced with the dual threat of a rapidly spreading viral illness and economic slowdown, a new study published on the preprint server medRxiv in May 2020 says that relaxing non-pharmacological interventions will allow the SARS-CoV-2 virus to become endemic.

13 May 2020

COVID-19 lockdown exit strategies: deliverance or disaster?

A new study by researchers at the University of Cambridge, Universidad de Sevilla, and the University of Massachusetts, published on the preprint server medRxiv in May 2020, shows that it is essential to choose a restrictive exit strategy while easing COVID-19 lockdowns, because failure to do so may lead to catastrophic results.

13 May 2020

Researchers identify CoV Mac1 proteins as a potential SARS-CoV-2 drug target

A recent study by researchers at the University of Kansas and published on the preprint server bioRxiv* reveals that Mac1 protein implicated in the infection process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a strikingly similar structure and activity in all coronaviruses – suggesting that possible future treatments targeting this protein may exert broad antiviral activity.

13 May 2020

U of A researchers and Tonix Pharmaceuticals join forces to develop, test COVID-19 vaccine

University of Alberta researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to develop and test a vaccine against COVID-19.

13 May 2020

Vaccine design can face specific challenges, say researchers

The goal of a vaccine is to trigger a response that safely protects against an infection and/or the burden of disease.

13 May 2020

USP launches new program to accelerate the development of effective COVID-19 treatments

To accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments, the U.S. Pharmacopeia has launched a new program to support scientists, developers and manufacturers worldwide.

13 May 2020

New method to control inflammatory response induced by COVID-19

Severe COVID-19 illness can result in excessive inflammation throughout the body, including the lungs, heart and brain. University of Minnesota Twin Cities student Molly Gilligan recently published an article in the journal Cancer & Metastasis Reviews that studied the human body's robust inflammatory response to the SARS-CoV-2 virus, which is now recognized as a hallmark symptom.

13 May 2020

Passive immummization can offer instant, short-term fortification against infectious agents

The worldwide COVID-19 pandemic has infected more than 4 million people and killed close to 280,000.1 Finding a vaccine has become a global public health priority.

13 May 2020

The ‘new normal’ in post-COVID-19 dental practice

A new paper published in the British Dental Journal in May 2020 reports on the new ways of partnership between the dental industry and dental professionals, in view of the extremely high risk of aerosol production during dental procedures, to reduce the risk of passing on COVID-19 infection.

13 May 2020

Neovii and Tel Aviv University partner to develop novel COVID-19 vaccine

Ramot, Tel Aviv University's technology transfer company, and Neovii, a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license agreement to develop a novel and potentially life-saving COVID-19 vaccine.

12 May 2020

Rotavirus vaccination leads to a decrease in hospitalizations and deaths of children

Vaccination against rotavirus has led to a significant decrease in hospitalisations and deaths of children due to severe diarrhoea in the Western Pacific region, a new study has found.

12 May 2020

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.

12 May 2020

Deciding who can return to work after COVID-19 outbreak recedes

A new paper describes a strategy that could help decide which workers can safely go back to work once a lockdown is easing off. The study, published on the preprint server medRxiv* in May 2020, could help to apply required measures for serological testing and income replacement among affected workers with accuracy and completeness.

12 May 2020

Antiviral cocktail may help treat mild COVID-19 patients

The skyrocketing number of cases due to the coronavirus pandemic has taken a massive toll on the health systems in many countries. Since the advent of the coronavirus disease (COVID-19), hundred of research teams are racing to find an effective vaccine and treatment to combat the deadly infection. Now, a team of researchers in Hong Kong suggests that combining three existing antivirals may help treat COVID-19 patients.

12 May 2020

Collaborative approach is essential to speed up COVID-19 vaccine candidates, say NIH experts

A harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate vaccines to prevent COVID-19 is essential, scientific leaders write in a perspective published today in Science.

12 May 2020

Study may reveal why some people are more affected by Covid-19 than others

A group of researchers funded by the British Heart Foundation (BHF) have set-up a clinical study of NHS Healthcare Workers to better understand the spread of coronavirus (Covid-19), and why some people are more affected by the virus than others.

12 May 2020

Hydroxychloroquine is not effective against COVID-19, extensive U.S. study shows

Over the past few months, doctors resorted to repurposing medicines that have already been approved for other diseases to treat coronavirus patients. One drug that was widely used in the pandemic, hydroxychloroquine, has been found to be ineffective in treating the viral infection.

11 May 2020

Genomic sequences from all over the world help fight SARS-CoV-2

As the COVID-19 pandemic rages across the world, killing hundreds of thousands and infecting over 4.1 million, researchers are racing against time to understand the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 genome has now been sequenced in many different regions of the world, and researchers are collaborating by sharing information to better understand the make-up and mutations that the virus has undergone.

11 May 2020